Seizure News and Research

Latest Seizure News and Research

Cell transplant treatment for diabetics gets the green light in the UK

Sufferers in the UK with Type 1 diabetes have been given new hope of a cure with a nationwide cell transplant programme.

11 Feb 2008

FDA to stop the marketing of unapproved injectable colchicine

The U.S. Food and Drug Administration has announced its intention to take enforcement action against companies marketing unapproved injectable colchicine, a drug used to treat gout.

7 Feb 2008

Chemical chaperone could open door to treatment of neurological disorder

An unexpected finding turned out to be a clue leading researchers at Washington University School of Medicine in St. Louis to propose a new treatment approach for Niemann-Pick disease, a rare, deadly neurodegenerative disorder.

7 Feb 2008

Enbrel shown to significantly reduced levels of C-reactive protein

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.

5 Feb 2008

Deafness and seizures result when glutamate protein deleted in mice

Scientists have discovered that mice genetically engineered to lack a particular protein in the brain have profound deafness and seizures.

25 Jan 2008

Auditory neurons in humans far more sensitive to fine sound frequencies than most mammals

The human ear is exquisitely tuned to discern different sound frequencies, whether such tones are high or low, near or far.

11 Jan 2008

Bio-identical hormone replacement therapies targeted by FDA

The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency.

10 Jan 2008

Discovery of a core mechanism underlying Fragile X syndrome

Researchers at UT Southwestern Medical Center are uncovering how brain cells are affected in Fragile X syndrome, the most common cause of inherited mental retardation and the most common genetic cause of autism.

9 Jan 2008

New gene identified for cerebral venous thrombosis

Researchers have identified a new gene linked to cerebral venous thrombosis, a condition that causes blood clots in the veins of the brain that can lead to stroke.

8 Jan 2008

Inquest into epidural blunder finds hospital at fault

An inquest in Britain into the death of a nurse within two hours of giving birth at the hospital where she worked as a theatre nurse, has heard that an epidural anaesthetic was mistakenly fed into her arm instead of her back.

7 Jan 2008

The dopamine transporter gene influences alcohol withdrawal seizures

The physiological component of alcoholism is defined by tolerance and/or withdrawal: the more severe the dependency on alcohol, the more severe the clinical complications, such as greater intensity and/or complications of alcohol withdrawal.

4 Jan 2008

Energy efficient bulbs blamed for triggering migraines

According to a British migraine lobby group, energy efficient light bulbs could be causing migraines.

3 Jan 2008

New hope for Batten disease sufferers

Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease – a rare neurodegenerative disease that strikes seemingly healthy kids, progressively robs them of their abilities to see, reason and move, and ultimately kills them in their young twenties.

3 Jan 2008

Epilepsy and brain pathology linked together by the protein ADK

The brain of individuals who suffer from epilepsy is characterized by astrogliosis, a brain pathology evidenced by a complex series of changes in the morphology and function of brain cells known as astrocytes.

3 Jan 2008

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

AstraZeneca has announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.

3 Jan 2008

Tweaking a gene may fix Fragile X syndrome

According to new research clues to Fragile X syndrome may be connected to one single human gene.

20 Dec 2007

Early treatment stops epilepsy in its tracks

Yale School of Medicine researchers have shown for the first time that it is possible to suppress the development of epilepsy in genetically predisposed animals - which could open the door to treating epilepsy as a preventable disease.

14 Dec 2007

New ray of hope for children with Batten disease

Investigators at the University of Rochester Medical Center have uncovered a promising drug therapy that offers a ray of hope for children with Batten disease

13 Dec 2007

Children with sickle cell disease, silent strokes show some relief with blood transfusions

A group of children who have sickle cell disease and who experience silent strokes showed some relief from the silent strokes with blood transfusion therapy, researchers at Washington University School of Medicine in St. Louis have found.

10 Dec 2007

Genetic animal model of autism

By introducing a gene mutation in mice, investigators have created what they believe to be the first accurate model of autism not associated with a broader neuropsychiatric syndrome, according to research presented at the American College of Neuropsychopharmacology annual meeting.

10 Dec 2007